SOURCE: Cypress Bioscience, Inc.

September 24, 2007 06:30 ET

Cypress Bioscience, Inc. to Present at UBS Global Life Sciences Conference

SAN DIEGO, CA--(Marketwire - September 24, 2007) - Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Sabrina Martucci Johnson, its Chief Business Officer and Chief Financial Officer, will present at the UBS Global Life Sciences Conference on Tuesday, September 25, 2007.

The UBS conference is being held at the Grand Hyatt Hotel, New York, NY. Ms. Johnson is scheduled to present on Tuesday, September 25th at 11:30 a.m. Eastern Time.

Investors, analysts and the general public are invited to listen to a live audio broadcast of this presentation over the Internet. The broadcast can be accessed at www.ibb.ubs.com (click on Conferences link).

A replay of the presentation will be available at the same web address as well as on Cypress' website, http://www.cypressbio.com/news/events.php.

About Cypress Bioscience, Inc.

Cypress is committed to be the innovator and leader in providing products that improve the treatment of Functional Somatic Syndromes and other central nervous system conditions. Cypress' strategy involves acquiring/in-licensing undervalued central nervous system active compounds and developing them for new indications.

For more information about Cypress, please visit the Company's website at www.cypressbio.com.

Contact Information

  • For additional information please contact
    For Cypress Bioscience:

    Sabrina Martucci Johnson
    Executive VP, Chief Business Officer
    and Chief Financial Officer

    Mary Gieson
    Investor Relations
    (858) 452-2323